Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aimee C Hodowanec

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Seminars in Dialysis|August 2, 2011
When should INH prophylaxis be given to a dialysis patient with a positive tuberculin skin test but with a normal CXR?Aimee C Hodowanec, Gordon M Trenholme
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
BK virus screening and management practices among US renal transplant programs: a surveyAimee C Hodowanec, David M Simon
Clinical Transplantation|September 5, 2015
Poor positive predictive value of influenza-like illness criteria in adult transplant patients: a case for multiplex respiratory virus PCR testingJonathan A Claus, Aimee C Hodowanec, Kamaljit Singh
The Journal of Infectious Diseases|March 6, 2020
The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory PerspectiveAimee C Hodowanec, Andreas Pikis, Mary E Singer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public HealthVikram Arya, Aimee C Hodowanec, Stephanie B Troy, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 30, 2012
Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literatureAimee C Hodowanec, Alice Han, David E Barker, et al.
Pathogens & Immunity|March 1, 2019
Increased CMV IgG Antibody Titer is Associated with Non-AIDS Events among Virologically Suppressed HIV-Positive PersonsAimee C Hodowanec, Nell S Lurain, Supriya Krishnan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2022
Reply to AuthorHannah Imlay, Aimee C Hodowanec, Takashi E Komatsu, et al.
Journal of Clinical Pharmacology|December 27, 2018
Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future PerspectivesAimee C Hodowanec, Andreas Pikis, Takashi E Komatsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2013
Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patientsAimee C Hodowanec, Kirsten E Brady, Weihua Gao, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Seminars in Dialysis|August 2, 2011
When should INH prophylaxis be given to a dialysis patient with a positive tuberculin skin test but with a normal CXR?Aimee C Hodowanec, Gordon M Trenholme
Transplant International : Official Journal of the European Society for Organ Transplantation|May 12, 2015
BK virus screening and management practices among US renal transplant programs: a surveyAimee C Hodowanec, David M Simon
Clinical Transplantation|September 5, 2015
Poor positive predictive value of influenza-like illness criteria in adult transplant patients: a case for multiplex respiratory virus PCR testingJonathan A Claus, Aimee C Hodowanec, Kamaljit Singh
The Journal of Infectious Diseases|March 6, 2020
The Development of Therapeutics for the Treatment and Prevention of CMV Disease in the Transplant Population: A Regulatory PerspectiveAimee C Hodowanec, Andreas Pikis, Mary E Singer
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public HealthVikram Arya, Aimee C Hodowanec, Stephanie B Troy, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 30, 2012
Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literatureAimee C Hodowanec, Alice Han, David E Barker, et al.
Pathogens & Immunity|March 1, 2019
Increased CMV IgG Antibody Titer is Associated with Non-AIDS Events among Virologically Suppressed HIV-Positive PersonsAimee C Hodowanec, Nell S Lurain, Supriya Krishnan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2022
Reply to AuthorHannah Imlay, Aimee C Hodowanec, Takashi E Komatsu, et al.
Journal of Clinical Pharmacology|December 27, 2018
Treatment and Prevention of CMV Disease in Transplant Recipients: Current Knowledge and Future PerspectivesAimee C Hodowanec, Andreas Pikis, Takashi E Komatsu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2013
Characterization of CD4⁺ T-cell immune activation and interleukin 10 levels among HIV, hepatitis C virus, and HIV/HCV-coinfected patientsAimee C Hodowanec, Kirsten E Brady, Weihua Gao, et al.
Pageof 2